Literature DB >> 27129246

CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity.

Joel Jules1, Wei Chen2, Xu Feng1, Yi-Ping Li3.   

Abstract

CCAAT/enhancer-binding protein (C/EBPα) can appoint mouse bone marrow (MBM) cells to the osteoclast (OC) lineage for osteoclastogenesis. However, whether C/EBPα is also involved in OC differentiation and activity is unknown. Here we demonstrated that C/EBPα overexpression in MBM cells can promote OC differentiation and strongly induce the expression of the OC genes encoding the nuclear factor of activated T-cells, c1 (NFATc1), cathepsin K (Cstk), and tartrate-resistant acid phosphatase 5 (TRAP) with receptor activator of NF-κB ligand-evoked OC lineage priming. Furthermore, while investigating the specific stage of OC differentiation that is regulated by C/EBPα, our gene overexpression studies revealed that, although C/EBPα plays a stronger role in the early stage of OC differentiation, it is also involved in the later stage. Accordingly, C/EBPα knockdown drastically inhibits osteoclastogenesis and markedly abrogates the expression of NFATc1, Cstk, and TRAP during OC differentiation. Consistently, C/EBPα silencing revealed that, although lack of C/EBPα affects all stages of OC differentiation, it has more impact on the early stage. Importantly, we showed that ectopic expression of rat C/EBPα restores osteoclastogenesis in C/EBPα-depleted MBM cells. Furthermore, our subsequent functional assays showed that C/EBPα exhibits a dispensable role on actin ring formation by mature OCs but is critically involved in bone resorption by stimulating extracellular acidification and regulating cell survival. We revealed that C/EBPα is important for receptor activator of NF-κB ligand-induced Akt activation, which is crucial for OC survival. Collectively, these results indicate that C/EBPα functions throughout osteoclastogenesis as well as in OC function. This study provides additional understanding of the roles of C/EBPα in OC biology.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt PKB; CCAAT-enhancer-binding protein (C/EBP); bone; differentiation; osteoclast; transcription factor

Mesh:

Substances:

Year:  2016        PMID: 27129246      PMCID: PMC4965585          DOI: 10.1074/jbc.M115.674598

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

2.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

3.  Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.

Authors:  Sen Yang; Liang Hao; Matthew McConnell; Xuedong Zhou; Min Wang; Yan Zhang; John D Mountz; Michael Reddy; Paul D Eleazer; Yi-Ping Li; Wei Chen
Journal:  Bone Res       Date:  2013-09-01       Impact factor: 13.567

4.  C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4.

Authors:  H Wang; P Iakova; M Wilde; A Welm; T Goode; W J Roesler; N A Timchenko
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

5.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 6.  Disorders of bone remodeling.

Authors:  Xu Feng; Jay M McDonald
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

7.  Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B.

Authors:  David Cappellen; Ngoc-Hong Luong-Nguyen; Sandrine Bongiovanni; Olivier Grenet; Christoph Wanke; Mira Susa
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

Review 8.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

9.  A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity.

Authors:  F T Lin; O A MacDougald; A M Diehl; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

Review 10.  The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control.

Authors:  Claus Nerlov
Journal:  Trends Cell Biol       Date:  2007-07-19       Impact factor: 20.808

View more
  10 in total

1.  C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.

Authors:  Wei Chen; Guochun Zhu; Jun Tang; Hou-De Zhou; Yi-Ping Li
Journal:  J Pathol       Date:  2018-01-29       Impact factor: 7.996

2.  Monocyte-Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function.

Authors:  Wei Chen; Guochun Zhu; Joel Jules; Diep Nguyen; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2018-01-26       Impact factor: 6.741

3.  C/EBPα transcription factor is regulated by the RANK cytoplasmic 535IVVY538 motif and stimulates osteoclastogenesis more strongly than c-Fos.

Authors:  Joel Jules; Wei Chen; Xu Feng; Yi-Ping Li
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

4.  C/EBPα and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis.

Authors:  Joel Jules; Yi-Ping Li; Wei Chen
Journal:  Bone       Date:  2017-10-12       Impact factor: 4.398

5.  GPR125 positively regulates osteoclastogenesis potentially through AKT-NF-κB and MAPK signaling pathways.

Authors:  Chen-Yi Tang; He Wang; Yan Zhang; Zhongliang Wang; Guochun Zhu; Abigail McVicar; Yi-Ping Li; Wei Chen
Journal:  Int J Biol Sci       Date:  2022-03-06       Impact factor: 6.580

6.  Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis.

Authors:  Guochun Zhu; Wei Chen; Chen-Yi Tang; Abigail McVicar; Diep Edwards; Jinwen Wang; Matthew McConnell; Shuying Yang; Yang Li; Zhijie Chang; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

Review 7.  Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis.

Authors:  Xin Zhao; Suryaji Patil; Fang Xu; Xiao Lin; Airong Qian
Journal:  Biomolecules       Date:  2021-05-17

8.  The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure.

Authors:  Rebecca K Davidson; Evan R Himes; Shinya Takigawa; Andy Chen; M Ryne Horn; Tomas Meijome; Joseph M Wallace; Melissa A Kacena; Hiroki Yokota; Andrew V Nguyen; Jiliang Li
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

9.  F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways.

Authors:  Yan Zhang; He Wang; Guochun Zhu; Airong Qian; Wei Chen
Journal:  Int J Biol Sci       Date:  2020-03-12       Impact factor: 6.580

Review 10.  At the Crossroads of the Adipocyte and Osteoclast Differentiation Programs: Future Therapeutic Perspectives.

Authors:  Shanmugam Muruganandan; Andreia M Ionescu; Christopher J Sinal
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.